Flanged interbody fusion device

Information

  • Patent Grant
  • 11364057
  • Patent Number
    11,364,057
  • Date Filed
    Wednesday, January 15, 2020
    4 years ago
  • Date Issued
    Tuesday, June 21, 2022
    a year ago
Abstract
Methods and devices are disclosed for treating the vertebral column. An implant for treating the spine is provided comprising at least two articulations between the spacer and the bone facing surface of the fixation plate. Another implant for treating the spine is also provided, comprising two or more fixation plates attached to a spacer with two or more articulations, wherein the fixation plates are independently movable.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

This invention relates generally to systems and methods for performing spinal fixation and, in particular, to interbody spacer devices.


Description of the Related Art

Advancing age, as well as injury, can lead to degenerative changes in the bones, discs, joints and ligaments of the spine, producing pain and instability. Under certain circumstances, alleviation of the problems can be provided by performing spinal fusion. Spinal fusion is a surgical technique where two or more vertebrae of the spinal column are fused together to eliminate the motion between the fused vertebrae. Spinal fusion is used to treat conditions where the spine exhibits instability. Spine instability may result from causes such as fracture, scoliosis and spondylolisthesis, where one or more vertebrae move in a forward direction relative to the other vertebrae. Spinal fusion with discectomy is also performed for herniations of the discs. This surgery involves removal of the affected disc and fusion of the adjacent vertebrae. Traditionally, bone grafts have been used to fuse the vertebrae, but various types of vertebral implants have also been used.


The use of bone plate and bone screw fixation systems for treating injuries to bones is well established. In most instances, a bone plate is positioned over and surrounding the bone injury area and secured to the bone. The bone plate is secured to the bone by bone screws or other similar fasteners inserted through holes in the bone plate and into the bone itself. The screws are tightened so that the bone plate holds the bone to be treated in place in order to insure proper healing. Early fixation devices tended to be applicable only to long bone injuries with only limited uses for lower lumbar spinal injuries and disorders. The use of plate/screw fixation systems later expanded, however, to include more uses for spinal injuries, including fusion of vertebrae including fixation devices for treating cervical vertebrae injuries. Notwithstanding the foregoing, there remains a need for improved methods and devices for treating spinal instability.


In existing spinal fusion implants there have also been problems with loosening and backing out of screws, especially in the cervical vertebrae where the screws can back out into the patient's throat area. Backout is the exhibited tendency of bone screws, which affix the bone plate to the bone(s), to loosen with respect to both the plate and bone, resulting in poor fixation, fusion and ultimately, healing. Essentially, this loosening of the bone screw causes the screw to work itself out of the bone into which it is implanted. This results in the bone plate being poorly fixed in place thus becoming devoid of its fixation capabilities. Usually, backout is caused by the chronic stress of bodily movement. While such loosening can be benign if limited in scope, it can lead to complications such as complete failure of the fixation device or incomplete bone fusion. Backout is particularly prevalent in areas of high bodily stress and movement, such as the spine.


To alleviate backout and its associated problems, current systems utilize secondary locking screws, locking collars or other secondary locking devices that hold the bone screws in place after deployment within the bone. In most systems, the bone screw is affixed into the bone through an opening in a bone plate. A locking device is then inserted into the bone screw. The locking device engages the head of the bone screw and is tightened which results in the bone screw being fixed in place within the bone, thus preventing backout.


While a locking screw or collar can alleviate backout, successful use of such locking device systems in the anterior cervical spine is particularly difficult because of anatomic constraints. Systems using multiple types of screws or collars to hold the bone screw in place are difficult to deploy within the confines of a small operating area available at the cervical spine. Furthermore, due to the small operating area, the surgeon implanting the device has great difficulty determining if the device is properly deployed. Any instrumentation implanted in the region must be minimally intrusive, yet have adequate strength to withstand the biomechanical loads to which it will be subjected. Thus, while current systems can help reduce instances of backout, their complex nature makes proper deployment very difficult and increases the chance of surgical error.


There is a need for an implant having a locking mechanism that can be easily and reliably locked in place to prevent the loosening of and backing out of the bone screws used to attach the implant to the vertebrae in the anterior aspect of the cervical, thoracic, and lumbar spine.


There is also a need for implants that can be implanted along a series of adjacent vertebrae. Implants adapted for use in the lumbar spine and the thoracic spine become much less usable in the cervical spine because of differences in anatomy. In the lumbar spine, the disc spaces are about 25% as tall as the vertebral bodies (i.e., the vertebral bodies are generally four times taller than the intervening disc space). In the cervical spine, the disc space can be 50% of the height of the vertebral bodies. The disc spaces in the cervical spine are generally not greater than 7 or 8 mm tall in most people.


Attachment of one fixation plate between two vertebrae often prevents the attachment of additional fixation plates between one of two vertebrae and an adjacent vertebra. This is especially true in the cervical spine region. The attachment of one fixation plate will reduce the surface area available to attach another fixation plate due to the small size of the cervical vertebrae and the minimum size required for each fixation plate. Because of this limitation in existing spinal fixation devices, treatment of spinal disorders may be suboptimal because disease in adjacent vertebrae cannot be treated adequately.


SUMMARY OF THE INVENTION

Devices and methods are disclosed for treating the vertebral column. An integrated fixation plate and spacer is provided with at least two articulations between the fixation plate and spacer. In some embodiments, an implant for treating the spine is provided comprising a fixation plate having an access surface and a bone facing surface, an upper portion and a lower portion, a spacer, and at least two articulations between the spacer and the bone facing surface of the fixation plate. In some embodiments, the at least two articulations provide for pivotable articulation and anterior-posterior movement between the spacer and the fixation plate.


In some embodiments, an implant for treating the spine is provided, comprising two or more fixation plates, a spacer, and two or more articulations between the spacer and the two or more fixation plate, wherein the two or more fixation plates are independently movable.


In some embodiments, a method for treating a spine is provided, comprising: providing an implant for treating the spine comprising a first and a second fixation plates, a spacer, and a first and a second articulations between the spacer and the first and the second fixation plates, wherein the fixation plates are independently movable, inserting the spacer into an intervertebral space between a first vertebra and a second vertebra, positioning the first fixation plate to lie generally flat on the first vertebra, attaching the first fixation plate to the first vertebra, positioning the second fixation plate in generally the opposite direction as the first fixation plate to lie generally flat on the second vertebra, and attaching the second fixation plate to the second vertebra.


The above embodiments and methods of use are explained in more detail below.





BRIEF DESCRIPTION OF THE DRAWINGS

The structure and method of using the invention will be better understood with the following detailed description of embodiments of the invention, along with the accompanying illustrations, in which:



FIG. 1 is a lateral elevational view of a portion of the vertebral column.



FIGS. 2A and 2B are superior and lateral elevational views of a thoracic vertebra.



FIG. 3 illustrates a superior elevational view of a cervical vertebra.



FIG. 4 represents a superior elevational view of a lumbar vertebra.



FIGS. 5A to 5D are various views of an embodiment of a pivotal fixation plate and spacer device.



FIGS. 6A to 6D are various views of an embodiment of an integrated fixation plate and spacer device with at least two articulations.



FIGS. 7A to 7D are various views of an embodiment of an integrated fixation plate and spacer device with more than one plate.



FIG. 8 is an isometric elevational view of an embodiment of a fastener retaining assembly.



FIG. 9 is a cross-sectional view of a fixation device with the fastener retaining assembly of FIG. 8 and an inserted screw.



FIG. 10A is a cross-sectional view of another embodiment of a fastener with an expansion ring. FIG. 10B is an exploded view of the fastener and expansion ring in FIG. 10A.



FIG. 11 is a cross-sectional view of an embodiment of a fastener with an expansion ring.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
A. Anatomy of the Spine

As shown in FIG. 1, the vertebral column 2 comprises a series of alternating vertebrae 4 and fibrous discs 6 that provide axial support and movement to the upper portions of the body. The vertebral column 2 typically comprises thirty-three vertebrae 4, with seven cervical (C1-C7), twelve thoracic (T1-T12), five lumbar (L1-15), five fused sacral (S1-S5) and four fused coccygeal vertebrae. FIGS. 2A and 2B depict a typical thoracic vertebra. Each vertebra includes an anterior body 8 with a posterior arch 10. The posterior arch 10 comprises two pedicles 12 and two laminae 14 that join posteriorly to form a spinous process 16. Projecting from each side of the posterior arch 10 is a transverse 18, superior 20 and inferior articular process 22. The facets 24, 26 of the superior 20 and inferior articular processes 22 form facet joints 28 with the articular processes of the adjacent vertebrae.


The typical cervical vertebrae 30, shown in FIG. 3, differ from the other vertebrae with relatively larger spinal canals 32, oval shaped vertebral bodies 34, bifid spinous processes 36 and foramina 38 in their transverse processes 40. These foramina transversaria 38 contain the vertebral artery and vein. The first and second cervical vertebrae also further differentiated from the other vertebrae. The first cervical vertebra lacks a vertebral body and instead contains an anterior tubercle. Its superior articular facets articulate with the occipital condyles of the skull and are oriented in a roughly parasagittal plane. The cranium is able to slide forward and backwards on this vertebra. The second cervical vertebra contains an odontoid process, or dens, which projects superiorly from its body. It articulates with the anterior tubercle of the atlas, forming a pivot joint. Side to side movements of the head occur at this joint. The seventh cervical vertebra is sometimes considered atypical since it lacks a bifid spinous process.


Referring to FIG. 4, the typical lumbar vertebrae 42 is distinguishable from the other vertebrae by the absence of foramina transversaria and the absence of facets on the surface of the vertebral body 44. The lumbar vertebral bodies 44 are larger than the thoracic vertebral bodies and have thicker pedicles 46 and laminae 48 projecting posteriorly. The vertebral foramen 50 is triangular in shape and larger than the foramina in the thoracic spine but smaller than the foramina in the cervical spine. The superior 52 and inferior articular processes (not shown) project superiorly and inferiorly from the pedicles, respectively.


B. Flanged Spacer

In some embodiments, an interbody vertebral implant 100 can be provided. As shown in FIGS. 5A through 5D, in some embodiments, the implant 100 can comprise a stabilization or fixation plate 102 having an upper portion 104 and a lower portion 106, and a bone facing surface 108 and an access surface 110. In use, typically the bone facing surface 108 can actually contact the vertebral bone surface, but in other embodiments, other structures or components can lie in between the bone facing surface 108 and the bone surface of the vertebra. Each upper portion 104 and lower portion 106 can have one or more spaces or holes 112 oriented between the bone facing surface 108 and the access surface 110 that are configured to accept screws and/or other attachment devices for anchoring the implant 100 to the vertebral bone. One or more spacers or spacing structures 114 can be located on the bone facing surface 108 of the fixation plate 102. The spacers 114 can be typically integrated with the fixation plate 102 about the bone facing surface 108.


1. Spacer Component


The spacer can comprise any structure configured to maintain a separation and resist compression between two adjacent vertebral bodies. The spacer can have any of a variety of overall shapes, including but not limited to a rectangular box, a trapezoidal box, H-shaped, O-shaped, V-shaped, with or without one or more lumens within the spacing structure. As shown in FIGS. 5A through 5D, the spacer 114 can have a base 116, a superior surface 118 and an inferior surface 120, and side surfaces 122, 124, and a posterior surface 126. Each surface 118, 120, 122, 124, 126 need not be flat, and can be curved or undulating or any combination thereof. The upper and lower surfaces 118, 120 can be configured for facing the superior and inferior vertebral bodies 8 or 34 adjacent to an implantation site. The relative configuration of the upper surface 118 and lower surface 120 can vary, depending upon the relative position desired between the two adjacent vertebrae, the anatomical shape of the vertebrae, ease of insertion of the implant and other factors. For example, if a neutral vertical alignment is desired between two vertebrae, the upper and lower surfaces 118, 120 can have generally parallel planar orientations. If a non-neutral alignment is desired, for instance to maintain a natural spinal curvature in the cervical region, the upper and lower surfaces 118, 120 can have a wedge-like relationship to allow fixation of the vertebrae in the desired non-neutral position. A non-neutral alignment with respect to the anterior-posterior direction can also be used to compensate for excessive lordosis or kyphosis in other portions of the vertebral column. The height of the spacing structure 114 at any section between the upper and lower surfaces 118, 120 can be further configured to accommodate degenerative changes or anatomical anomalies to provide fixation in the desired relative position. Likewise, the side surfaces 122, 124 of the spacing structure 114 can be generally parallel or skewed. In some embodiments, the side surfaces 122, 124 of the implant 100 taper with increasing distance from the base 116 of the implant 100. A tapered spacing structure can facilitate insertion of the implant 100 into the intervertebral space. In other embodiments, the one or more side surfaces can flare distally or have both tapering and flaring portions.



FIGS. 5A through 5D illustrate an embodiment comprising a spacer 114 with windows or holes 146, 152 between the outer side surfaces 122, 124 and inner side surface 150 of the posterior member. These windows or holes can allow bony growth into the windows or holes. The space 146, 152 within and/or between the posterior members can also be filled with graft materials (not shown). The graft material can be an autograft, allograft, xenograft or synthetic material. Synthetic graft material can be ceramic-based, silicon-based or calcium-based. The graft material can also include osteoinductive factors to promote bone ingrowth. One skilled in the art will appreciate that there are many varieties of synthetic graft materials and constituents that can be used between or about the hyoid bone segments.


One or more surfaces of the implant can also have surface projections, indentations, or holes or pores that can further alter the characteristics of the implant. Referring to FIGS. 5A through 5D, in some embodiments, angled projections, barbs, teeth 154 or ramped surfaces which incline outwardly from one or more spacer surfaces toward the fixation plate 102 can be provided on one or more surfaces that allow insertion of the spacing structure in one direction but resist movement in the opposite direction. These teeth 154 can be advantageous in reducing the migration of the device out of the intervertebral space. Improved fixation of the spacer 114 can maintain device position during drilling of the screw holes into the vertebral bodies, and can also reduce the forces acting upon the screws or other retaining structures, thereby reducing the risk of backout. The teeth 154 are preferably provided on the superior and/or inferior surfaces 118, 120 of the spacer 114, but other surfaces can also have teeth or other tissue engagement structures.


In some embodiments, the tissue engagement structures can be combined with indentations, holes or pores for allowing bony ingrowth or filling with bony matrix or graft materials as previously described. These holes can be utilized with other surface features to further enhance insertion and stabilization of the implant.


In some embodiments, the spacer can have a height of about 4 mm to about 50 mm, or preferably about 4 mm to about 12 mm. In some embodiments, the spacer can have a height of about 6 mm to about 9 mm. In some embodiments, the spacer can have a length as measured from the bone facing surface of the fixation plate to the most posterior end of the spacer of about 5 mm to about 25 mm. In some embodiments, the spacer length can be about 10 mm to about 15 mm. The width of the spacer can be generally about 5 mm to about 25 mm, and in some situations, about 10 mm to about 15 mm. One skilled in the art can dimension the spacer based upon the implantation location and specific vertebral morphology, neurological anatomy and disease state.


The spinal fusion implant can include, be made of, treated, coated, filled, used in combination with, or contain artificial or naturally occurring materials suitable for implantation in the human spine. These materials can include any source of osteogenesis, bone growth-promoting materials, bone derived substances, bone morphogenetic proteins, hydroxyapatite, genes coding for the production of bone, and bone including, but not limited to, cortical bone. The implant can also be formed of material such as metal including, but not limited to, titanium and its alloys, surgical grade plastics, plastic composites, ceramics, or other materials suitable for use as a spinal fusion implant. In some embodiments, the device can comprise a radiolucent material, a radio-opaque material, or a combination thereof. A device that is partially or completely radiolucent can be advantageous when evaluating the effect of the implant post-implantation. Many existing spinal fixation plates and/or spacers obscure visualization of the vertebrae, which can complicate post-operative treatment, diagnosis and prognosis of the patient's condition. The implant can include at least in part materials that are bioabsorbable in the body. The implant of the described embodiments can be formed of a porous material or can be formed of a material that intrinsically participates in the growth of bone from one of adjacent vertebral bodies to the other of adjacent vertebral bodies. The implant can be treated with, coated with, or used in combination with substances to inhibit scar tissue formation. The implant of the described embodiments can be modified, or used in combination with materials to provide antibacterial properties, such as, but not limited to, electroplating or plasma spraying with silver ions or other substance. The implant can optionally comprise an electrical source to provide ionophoresis of the silver ions into the surrounding tissue to prevent infection. The antibacterial properties can include bactericidal and/or bacteriostatic characteristics. Similarly, anti-fungal characteristics can also be provided. Any of these materials as appropriate can be used at any time after the implant(s) are inserted.


2. Fixation Component


The fixation plate can have a generally flat configuration, curved configuration or combination thereof. Optionally, each surface of the fixation plate can also have a generally flat or curved configuration or combination thereof. Each surface of the fixation plate need not have the same configuration. The edges of the fixation plate can optionally be rounded, smoothed or polished. In some embodiments, the flange can be dimensioned such that the flange extends about 2 mm beyond the edges of the base of the spacer. In some embodiments, the fixation component can be dimensioned to extend generally about 1 mm to about 20 mm beyond the perimeter of the spacer component at its interface with the fixation plate. In other embodiments, the flange can extend by 3 mm or 4 mm or more beyond the spacer base. The flange may or may not extend uniformly along the spacer edges. The shape of the flange can be different from the shape of the spacer base.


In some embodiments, illustrated in FIGS. 5A through 5D, the flange 102 of implant 100 can have a general square or rectangular shape and is dimensioned to allow stable attachment of the implant 100 to the adjacent vertebral bodies 8. The corners where any two sides of the flange meet can be angled, rounded or curved. The flanged implant 100 depicted in FIGS. 5A through 5D can comprise rounded corners. In other embodiments, the flange 102 can comprise any of a variety of other shapes, including trapezoids, circles, ovals, polygons or other closed shapes. The flange 102 may or may not have a symmetrical configuration with respect the upper and lower portions and/or the left and right portions of the flange.


In some embodiments, the average thickness of the fixation plate can be within the range of about 1 mm to about 5 mm. In other embodiments, the average thickness of the fixation plate can be within the range of about 1.5 mm to about 3.0 mm. The thicknesses of the fixation plate need not to be uniform. In some embodiments, the fixation plate can be conformable to the vertebral surfaces of the implantation sites.


In some embodiments, the spacer component can be attached to a fixation component comprising a mesh or lattice. The fixation component can also be made from a material that is the same or different from the spacer component. In some instances a fixation component and a spacer component having different materials can be beneficial because the spacer component can be configured to withstand compressive forces while the fixation component is configured to withstand primarily tension forces. The fixation component can comprise a polymer, a woven material, or a combination thereof.


In some embodiments, the flange 102 can be configured for positioning across an intervertebral space such that the upper portion 104 of the flange 102 can be adapted to contact the superior vertebra and the lower portion 106 of the flange 102 can be adapted to contact the inferior vertebra about an intervertebral space. In some embodiments, the flange 102 can be configured to contact a single vertebra about an intervertebral space, or more than two vertebrae. In some embodiments, the flange 102 can span two or more intervertebral spaces. Typically, the implant 100 can be adapted for positioning about the anterior surface of the vertebrae, along the anterior surfaces of vertebral bodies. In some instances, the flange 102 of the implant 100 can also be configured to contact other vertebral structures such as the pedicles, transverse processes, facet joints, superior and inferior articular processes and spinous processes. In still other embodiments, the implant 100 can be configured to attach to these vertebral structures without attaching or contacting the vertebral bodies.


Referring back to FIGS. 5A through 5D, each upper portion and lower portion of the fixation plate 102 can have one or more spaces or holes 112 oriented between the bone facing surface 108 and access surface 110 that are configured to accept screws and/or other attachment elements for anchoring the implant to the vertebral bone. In some embodiments, one or more bone screws 158 configured for insertion through one or more screw holes 112 in the fixation plate 102 are provided.


Each hole 112 of the flange or fixation plate 102 need not have the same configuration or size. The holes 112 can be round in cross-section and dimensioned to allow passage of a screw body therethrough while resisting passage of the screw head completely through the hole 112. In some embodiments, at least a portion of the hole 112 can have a non-round cross-section, such as an oval, square, rectangle, polygon or other closed shape. The inside surface of the holes 112 can be covered with a lubricious coating to facilitate insertion and/or movement of a screw or other attachment device through the hole.


In some embodiments, the flanged interbody device comprises a polyaryl polymer, including but not limited to PEK, PEEK, PEKK, PEKEKK or a blend thereof, and the insert comprises a titanium or titanium alloy. Other combination can also be used as is known by those with skill in the art.


C. Implantation Procedure

In some embodiments, the patient can be intubated and general anesthesia can be achieved. The patient can be prepped and draped in the usual sterile fashion. An anterior approach to the spine can be used to expose the anterior vertebral bodies. Many anterior approaches to the vertebral column are described in various medical texts such as Campbell's Operative Orthopaedics, 10th ed., edited by Canale et al., pp. 1569-1588, herein incorporated by reference. In some embodiments, the upper cervical spine can be accessed. The anterior upper cervical spine can be accessed by a transoral or retropharyngeal route, or by using a subtotal or extended maxillotomy. In other embodiments, the lower cervical spine, cervicothoracic junction, thoracic spine, thoracolumbar junction, lumbar region, lumbosacral junction, sacrum or combination of the above regions can be accessed.


The intervertebral space can be debrided. In some embodiments, the flanged interbody implant can be packed with natural or artificial bone matrix and/or other osteogenesis factors and inserted into the intervertebral space. The flange can be positioned against the anterior cervical vertebral bodies and attached with screws or anchors. The operative site can be irrigated with antibiotics and the operative field can be sutured closed. The vertebral column can be accessed and one or more intervertebral spaces can be identified and accessed. In some embodiments, two or more intervertebral spaces can be accessed, and in still other embodiments, two or more adjacent intervertebral spaces can be accessed. The operative site can be rinsed with antibiotic solution and the operative field can be closed in layers.


In another embodiment, a method for treating a spine can comprise the steps of providing an implant for treating the spine comprising two or more fixation plates, a spacer, and two or more articulation between the spacer and the two or more fixation plates, wherein the fixation plates are independently movable. The spacer can be inserted into an intervertebral space between a first vertebra and a second vertebra. One of the fixation plates can be positioned to lie generally flat on the first vertebra and can be attached to the first vertebra. A second fixation plate can be positioned in generally the opposite direction as the first fixation plate to lie generally flat on the second vertebra and can be attached to the second vertebra. Any remaining fixation plates can further be positioned to lie generally flat on the first or second vertebra and attached to the vertebra.


In some embodiments, the method for treating a spine can further comprise providing a second implant for treating the spine comprising two or more fixation plates, a spacer, and two or more articulations between the spacer and the two or more fixation plates, wherein the fixation plates are independently movable. The spacer of the second implant can be inserted into a second intervertebral space between the second vertebra and a third vertebra, wherein the second intervertebral space is next to the first intervertebral space along a vertebral column. One of the fixation plates of the second implant can be positioned to lie generally flat on the second vertebra and complementary to the second fixation plate of the first implant and can be attached to the second vertebra. In embodiments with two fixation plates, when the left fixation plate of the first implant is fixed to the second vertebra, the right fixation plate of the second implant can be attached to the second vertebra, so the left fixation plate of the first implant is positioned next to the right fixation plate of the second implant on the second vertebra. A second fixation plate of the second implant can be positioned in generally the opposite direction as the first fixation plate of the second implant to lie generally flat on the third vertebra and can be attached to the third vertebra. In another embodiment, the method for treating a spine can further comprises providing a third or additional implants for treating the spine and implanting according to the method for the second implant.


D. Pivot Plate

In some embodiments of the invention, the interbody spacer and the fixation plate can be configured to provide some degree of relative movement between each other. By providing some relative movement between the interbody spacer and fixation plate portions, the device can have improved securement to osseous structures with improved conformance to the existing anatomy at the site of implantation. FIGS. 5A through 5D depict an embodiment comprising a hinge joint 128 oriented to allow pivoting of the fixation plate 102 relative to the spacer 114. In the illustrated embodiment, the hinge joint 128 is oriented to allow pivoting in the sagittal plane. In other embodiments of the invention, the hinge joint 128 can be oriented to allow pivoting in other planes such as the transverse plane, coronal plane, or any plane in between the three planes. The joint provided between the interbody spacer 114 and the fixation plate 102 can be further configured to limit the range of movement provided. In other embodiments, the configuration of the interbody spacer 114 and/or fixation plate 102 can restrict the relative range of motion between the two components. Recesses in the fixation plate 102 or a size reduction or tapering of the interbody spacer 114 about the movement joint 128 can provide clearance to allow greater range of movement between the fixation plate 102 and the spacer 114. One of skill in the art will understand that the movement joint 128 may be configured to vary other characteristics of the movement joint, including frictional resistance or ratchet-type resistance to movement. Although the hinge joint in FIGS. 5A to 5D are depicted in a symmetric position on the interbody spacer and fixation plate, an eccentric location may be used.


Although a hinge-type movement joint is depicted in FIGS. 5A to 5D, other types of joints or connections between the interbody spacer component and fixation plate are also contemplated, including but not limited to an elastomeric joint, a ball-and-socket joint, a sliding joint, a rotatable articulation configured to allow reversible separation of the fixation plate and spacer, or one or more metallic cords embedded or attached between the fixation plate and interbody spacer to allow limited polyaxial movement.


Moreover, although a single interbody spacer 114, fixation plate 102 and movement joint 128 are depicted, other embodiments can have two or more movement joints and wherein either the fixation plate and/or interbody spacer can have a split configuration so that each split component has its own movement joint and can independently move or pivot to provide additional conformance to the existing anatomy.


In still other embodiments, the fixation plate 102 and/or interbody spacer 114 can be configured with two or more subcomponents that are provided with an intracomponent hinge or movement joint to provide better conformance of the device to the existing anatomy. For example, the fixation plate component of the device can be configured as left and right subcomponents with a hinge joint in-between. In another example, the interbody spacer can have superior and inferior subcomponents with a hinge joint therebetween to allow pivoting of the superior and inferior surfaces of the interbody spacer. Depending on the orientation of the hinge joint, the superior and inferior surfaces of the interbody spacer can pivot laterally or in an anterior-posterior direction, or any direction in-between.


E. Multi-Axial Movement Fixation Plate

In some embodiments, multiple joints between the interbody spacer and the fixation plate can be configured to provide additional degrees of movement relative to each other. By providing adjustment of the fixation plate in multiple degrees of movement relative to the interbody spacer, securement to osseous structures can be improved while also improving conformance to the existing anatomy at the site of implantation. FIGS. 6A through 6D illustrate an implant 200 comprising a double hinge joint 260 and single hinge joint 262 disposed to allow multiple degrees of movement. The double hinge joint 260 can move in a circular cam motion about the longitudinal axis of single hinge joint 262, or in an alternative description, the single hinge joint 262 can move in a circular cam motion about the longitudinal axis of the double hinge joint 260. The two hinge configuration can allow the spacer 214 and the fixation plate 202 to move in a circular and reciprocating movement relative to each other. The combination of the double hinge joint 260 and the single hinge joint 262 can permit the relative movement in both the anterior-posterior and the superior-inferior directions. Both the interbody spacer 214 and the fixation plate 202 can also have an additional degree of pivotal movement about the hinge joints 262 and 260. FIGS. 6A and 6B illustrate the device in the configuration where the distance between the spacer 214 and the fixation plate 202 is at its minimum. FIGS. 6C and 6D illustrate the device in the configuration where the distance between the spacer 214 and the fixation plate 202 is toward its maximum.


In some embodiments, the hinge joints 260 and 262 can be oriented to allow similar movements in any plane such as the sagittal plane, transverse plane, coronal plane, or any plane in-between the three planes. In some embodiments, the hinge joints 260 and 262 provided between the interbody spacer 214 and the fixation plate 202 can be configured to limit the range of movement provided. In some embodiments, the configuration of the interbody spacer 214 and/or fixation plate 202 can restrict the relative range of motion between the two components. In some embodiments, recesses in the fixation plate 202 or a size reduction or tapering of the interbody spacer component 214 about the hinge joints 260 and 262 can allow greater range of motion. The hinge joints 260 and 262 can be configured to vary other characteristics of the movement joints, including frictional resistance or ratchet-type resistance to movement. Although the hinge joints in FIGS. 6A through 6D are depicted in a symmetric position on the interbody space and fixation plate, an eccentric location can be used.


Although hinge-type movement joints are depicted in FIGS. 6A to 6D, other types of joints or connections between the interbody spacer component and fixation plate are also contemplated, including but not limited to elastomeric joints, ball-and-socket joints, sliding joints, rotatable articulations configured to allow reversible separation of the fixation plate and the spacer, or one or more metallic cords embedded or attached between the fixation plate and interbody spacer to allow limited polyaxial movement.


The hinge-type movement joints depicted in FIGS. 6A to 6D can advantageously allows the distance between the fixation plate 202 and the spacer 214 to be adjusted by the surgeon. In this manner, a single device can be adapted to individual anatomies. This can reduce the amount of inventory needed.


F. Multiple Pivot Plates

In some embodiments, the implant can comprise two or more fixation plates with independent movement joints, wherein each fixation plate is coupled to a separate movement joint that can independently move or pivot to provide additional conformance to the existing anatomy. FIGS. 7A through 7D depict such an implant 400, comprising an interbody spacer 414, a first fixation plate 470 coupled to the interbody spacer 414 by a first hinge joint 464, and a second fixation plate 472 coupled to the interbody spacer 414 by a second hinge joint 466. The hinge joints 464 and 466 can allow the pivotal movement between the interbody spacer 414 and the two fixation plates 470 and 472. In some embodiments, the fixation plates 470 and 472 can be pivoted to a predetermined position, such as generally parallel to the interbody spacer 414, so that the spacer 414 can present a low profile, as illustrated in FIGS. 7A and 7B. This configuration can be advantageous for insertion of the device into an intervertebral space in the body. In some embodiments, the fixation plates 470 and 472 can be pivoted so that they extend away from the interbody spacer 414, which can also advantageously serve insertion of the device. In some embodiments, the first fixation plate 470 can be pivoted to a position generally perpendicular to the interbody spacer 414, and coupled with a first vertebra, and the second fixation plate 472 can be pivoted in a direction opposite to the first fixation plate 470 to a position generally perpendicular to the interbody spacer 414 and coupled with a second vertebra. FIGS. 7C and 7D illustrate the implant 400 in this configuration. In some embodiments, the first and second fixation plates 470 and 472 can be independently pivoted to various positions at certain angles relative to the interbody spacer 414 for coupling with two adjacent vertebras.


In other embodiments, the hinge joints 464 and 466 can be oriented to allow pivoting in any plane such as the sagittal plane, transverse plane, coronal plane, or any plane in-between the three planes. The joints provided between the interbody spacer 414 and the fixation plates 470 and 472 can be further configured to limit the range of movement provided. In some embodiments, the configuration of the interbody spacer 414 and/or fixation plates 470 and 472 can restrict the relative range of motion between the components. In some embodiments, recesses in the fixation plates 470 and 472 or a size reduction or tapering of the interbody spacer component 414 about the movement joints 464 and 466 can allow greater range of motion between the components. The movement joints 464 and 466 can be configured to vary other characteristics of the movement joint, including frictional resistance or ratchet-type resistance to movement. In some embodiments, the joints 464 and 466 can each comprise multiple joints to provide multi-axial motion, as described above.


In other embodiments, the implant can include more than two fixation plates, with each fixation plate able to pivot to a position generally perpendicular or at any angle to the interbody spacer and couple with the first or second vertebra. Although the hinge joints in FIGS. 7A through 7D are depicted in a symmetric position on the interbody spacer and fixation plates, an eccentric location can be used.


Although a hinge-type movement joint is depicted in FIGS. 7A through 7D, other types of joints or connections between the interbody spacer component and fixation plates are also contemplated, including but not limited to elastomeric joints, ball-and-socket joints, sliding joints, rotatable articulations configured to allow reversible separation of the fixation plate and spacer, or one or more metallic cords embedded or attached between the fixation plate and interbody spacer to allow limited polyaxial movement. The above described spacer is particularly useful in embodiments in which a superior and inferior vertebrae are separated using pins or other devices. For example, in certain applications (e.g., in the cervical spine) elongate pins can be implanted into superior and inferior vertebrae and used as anchors to separate the vertebra from each other. The elongate pins can be implanted in an offset orientation, for example wherein a first elongate pin can be implanted on the left portion of a first vertebra and the second elongate pin can be implanted on the right portion of a second vertebra. The above described embodiments allow the flanges 470, 472 to be pivoted into the spaces on the vertebra not occupied by the pins. That is, one of the fixation plates can be positioned to lie generally flat on the right portion of the first vertebra and can be attached to the first vertebra. A second fixation plate can be positioned in generally the opposite direction as the first fixation plate to lie generally flat on the left portion of the second vertebra and can be attached to the second vertebra.


G. Alternative Screw Locks

In addition to the embodiments of the screw retaining assemblies described above, other screw retaining assemblies are also contemplated and can be used with the interbody fusion devices previously described. The other screw retaining assemblies described below can also be used with other types of orthopedic and medical devices, as well as non-medical applications, including but not limited to construction, home improvement, consumer appliance, electronic device and other applications.


1. Screw Retainer with Pivot Surface



FIGS. 8 and 9 depict some embodiments comprising an expandable fastener retaining ring 310 residing partially within an expansion groove 312 of a fastener lumen 112 and partially within the fastener lumen 112 itself. The retaining ring 310 can have a reduced configuration and an expanded configuration but can be biased to the reduced configuration. The retaining ring 310 can have a retaining segment 314 and a pivot segment 316. Referring to FIG. 9, the retaining segment 314 can have an enlarged outer diameter that is adapted to fit in an expansion groove 312. In the expanded configuration of the retaining ring 310, the retaining segment 314 can further expand into the expansion groove 312, thereby increasing the inner diameter 318 of the retaining segment 314. The inner diameter 318 of the retaining segment 314 can have a sloped inner surface 320 that narrows from the proximal opening 322 of the retaining ring 310. The sloped surface 320 can facilitate expansion of the retaining segment 314 as a fastener 158 is inserted through it. Once the fastener head 160 has passed through the retaining segment 314 of the retaining ring 310, the inner diameter 324 of the polyaxial segment 316 of the retaining ring 310 can be larger, allowing the fastener head 160 to reside in the retaining ring 310 without exerting an expansion force against the retaining ring 310. This can allow the retaining ring 310 to at least partially, if not completely, revert back to its reduced configuration. If backout forces are exerted on the fastener head 160, the fastener head 160 can abut a generally perpendicular retaining surface 232 located at the transition from the inner diameters 318, 324 of the retaining and polyaxial segments 314, 316 of the ring 310 and can resist fastener head 160 backout.


The polyaxial segment 316 of the retaining ring 310 can comprise a sloping reduced diameter 326 towards the distal opening 328 of the retaining ring 310, such that the smallest diameter of the polyaxial segment 316 can be smaller than the largest diameter of the fastener head 160 and can prevent or resist the fastener head 160 from passing completely through the retaining ring 310. The slope of the cross-section through the retaining ring can be linear, curved, toothed or jagged or any other sloped surface.


2. Fastener Head Embedded Expansion Lock


In some embodiments, illustrated in FIGS. 10A and 10B, the fastener 330 can comprise a secondary screw 332 and screw lumen 334 within the fastener head 336. An expandable ring 338 or disc, having a reduced and an expanded configuration, is provided within a groove 340 about the fastener head 336, with the expandable ring or disc biased to the reduced configuration. The groove 340 can be contiguous with screw lumen 334 of the fastener head 336 at one or more openings 342, such that the portion 344 of the inner surface 346 of the expandable ring 338 or disc partially protrudes into the screw lumen 334 when the expandable ring 338 or disc is in the reduced configuration. The secondary screw 332 of the fastener 330 can have an expansion section, typically the head 348 of the secondary screw 332, which can have an outer diameter 350 that is greater than the distance 352 within the screw lumen 334 where the expansion ring 338 or disc protrudes into the screw lumen 334. When the expansion section 348 of the secondary screw 332 is not in contact with the inner protruding portions 344 of the expandable ring 338 or disc, the expandable ring 338 or disc is able to remain in the reduced configuration. When the expansion section 348 of the secondary screw 332 is fully positioned against the protruding portions 344 of the expandable ring 338 or disc, it can act against the expandable ring 338 or disc and can cause the expandable ring 338 or disc to enlarge to its expanded configuration. In the expanded configuration, the outer diameter 354 of the expandable ring 338 or disc can be greater than the largest outer diameter of the remaining portions of the fastener 330. In the reduced configuration, the outer diameter of expandable ring or disc may or may not radially extend from out of the groove.


Referring to FIG. 11, the fastener 330 is preferably used in devices having one or more fastener lumens 356 with a proximal diameter 358, middle diameter 360 and distal diameter 362, wherein the proximal diameter 358 is greater than the distal diameter 362 but less than the middle diameter 360, and wherein the proximal diameter 358 is less than the outer diameter 364 of the expandable ring 354 or disc in the reduced configuration. The outer diameter of the expandable ring 338 or disc, in the expanded configuration, can be larger than the proximal diameter 358 of the fastener lumen 356, thereby preventing or resisting backout of the fastener 330. In some embodiments, as shown in FIG. 10A, the screw lumen can be lined by an hole insert 366 having a similar relationship of its proximal, middle and distal diameters. A hole insert 366 can be preferred, for example, when the orthopedic device utilizing the fastener system comprises a material that may exhibit wear from the metallic fasteners. A hole insert 366 can be provided to protect against such wear.


Referring again to FIG. 10A, the screw lumen 334 of the fastener 330 can extend distally from the openings 342 contiguous with the fastener head groove 340 to allow the secondary screw 332 to completely reside within the screw lumen 334 in a position distal to the screw lumen openings 342 and inner protrusions 344 of the expandable ring 338 or disc. This feature can allow the fastener 330 to be attached to the desired structure without having to later insert the secondary screw 332 into the fastener 330 to enlarge the expandable ring 338 or disc. Instead, once the fastener 330 is attached to the desired structure, the secondary screw 332 need only be moved proximally in the screw lumen 334 to act against the expandable ring 338 or disc and enlarge the expandable ring 338 or disc to its expanded configuration and to retain the fastener in place. By allowing the attachment of the fastener 330 with the secondary screw 332 already in place, the use of fastener 330 in cramped or limited access areas, such as the attachment of a cervical fusion plate or interbody fusion device, need not attempt to maintain a tiny secondary screw 332 on the end of an attachment device while attempting to align the tiny secondary screw 332 with the screw lumen 334 of the fastener head. The user of the fastener 330 only has to align the screwdriver of the secondary screw to the secondary screw in order to manipulate it.


H. Conclusion

Although the present invention has been described in relation to various exemplary embodiments, various additional embodiments and alterations to the described embodiments are contemplated within the scope of the invention. Thus, no part of the foregoing description should be interpreted to limit the scope of the invention as set forth in the following claims. For all of the embodiments described above, the steps of the methods need not be performed sequentially.

Claims
  • 1. An implant for treating the spine, comprising: a fixation plate having an access surface and a bone facing surface;a spacer; anda first articulation and a second articulation between the spacer and the bone facing surface of the fixation plate, the first articulation allowing for anterior and posterior movement between the spacer and the bone facing surface of the fixation plate, wherein the first articulation allows for a full rotation along a circular path, the second articulation allowing for superior and inferior movement between the spacer and the bone facing surface of the fixation plate.
  • 2. The implant for treating the spine of claim 1, wherein the first articulation comprises a hinge joint and the second articulation comprises a hinge joint.
  • 3. The implant for treating the spine of claim 1, wherein the fixation plate pivots about a longitudinal axis of the second articulation.
  • 4. The implant for treating the spine of claim 1, wherein the second articulation pivots to allow superior-inferior adjustment.
  • 5. The implant for treating the spine of claim 1, wherein an axis of rotation of the first articulation does not intersect the fixation plate.
  • 6. The implant for treating the spine of claim 1, wherein an axis of rotation of the first articulation is parallel to the fixation plate.
  • 7. The implant for treating the spine of claim 1, wherein the first articulation is configured to allow reversible anterior-posterior separation of the fixation plate and the spacer.
  • 8. The implant for treating the spine of claim 1, wherein the second articulation is configured to allow reversible superior-inferior pivoting of the fixation plate and the spacer.
  • 9. The implant for treating the spine of claim 1, wherein an axis of rotation of the second articulation does not intersect the fixation plate.
  • 10. The implant for treating the spine of claim 1, wherein an axis of rotation of the second articulation is parallel to the fixation plate.
  • 11. The implant for treating the spine of claim 1, wherein the second articulation allows for less than a full rotation along a second circular path.
  • 12. The implant for treating the spine of claim 1, wherein an axis of rotation of the first articulation and an axis of rotation of the second articulation are parallel.
  • 13. A method for treating a spine, comprising: positioning the implant of claim 1 relative to vertebrae, andadjusting the fixation plate anteriorly-posteriorly relative to the spacer.
  • 14. The method of claim 13, further comprising adjusting the fixation plate superiorly-inferiorly relative to the spacer.
  • 15. An implant for treating the spine, comprising: a fixation plate having an access surface and a bone facing surface;a spacer;a first articulation between the spacer and the bone facing surface of the fixation plate; anda second articulation between the spacer and the bone facing surface of the fixation plate,wherein in a first configuration, the distance between a first point of the fixation plate and a second point of the spacer is at a minimum,wherein in a second configuration, the distance between the first point of the fixation plate and the second point of the spacer is at a maximum,wherein the first articulation is configured to complete a circular path.
  • 16. The implant for treating the spine of claim 15, wherein the first articulation comprises a first hinge joint and the second articulation comprises a second hinge joint.
  • 17. The implant for treating the spine of claim 15, wherein the fixation plate pivots about a longitudinal axis of the second articulation.
  • 18. The implant for treating the spine of claim 17, wherein the second articulation pivots along a superior-inferior direction.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/938,503, filed Nov. 11, 2015, which is a divisional of U.S. patent application Ser. No. 12/748,333, filed Mar. 26, 2010, which claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application No. 61/164,029 filed on Mar. 27, 2009, the disclosure of each is incorporated by reference herein in its entirety.

US Referenced Citations (505)
Number Name Date Kind
1845428 Llewellyn Feb 1932 A
2440123 Smith Apr 1948 A
2500993 Christopher Mar 1950 A
2677369 Knowles May 1954 A
3426364 Lumb Feb 1969 A
3574381 Ocheltree et al. Apr 1971 A
3848601 Ma et al. Nov 1974 A
3867728 Stubstad et al. Feb 1975 A
3893196 Hochman Jul 1975 A
3953140 Carlstrom Apr 1976 A
3987499 Scharbach et al. Oct 1976 A
4013071 Rosenberg Mar 1977 A
4309777 Patil Jan 1982 A
4349921 Kuntz Sep 1982 A
4388921 Sutter et al. Jun 1983 A
4401112 Rezaian Aug 1983 A
4464090 Duran Aug 1984 A
4484570 Sutter et al. Nov 1984 A
4554914 Kapp et al. Nov 1985 A
4599086 Doty Jul 1986 A
4834757 Brantigan May 1989 A
4892545 Day et al. Jan 1990 A
4904261 Dove et al. Feb 1990 A
4917704 Frey et al. Apr 1990 A
4955908 Frey et al. Sep 1990 A
4961740 Ray et al. Oct 1990 A
5002576 Fuhrmann et al. Mar 1991 A
5053036 Perren et al. Oct 1991 A
5057111 Park Oct 1991 A
5085660 Lin Feb 1992 A
5147361 Ojima et al. Sep 1992 A
5147402 Bohler et al. Sep 1992 A
5176709 Branemark Jan 1993 A
5192327 Brantigan Mar 1993 A
5269784 Mast Dec 1993 A
5275601 Gogolewski et al. Jan 1994 A
5304179 Wagner Apr 1994 A
5306307 Senter et al. Apr 1994 A
5364399 Lowery et al. Nov 1994 A
5397364 Kozak et al. Mar 1995 A
5458641 Ramirez Jimenez Oct 1995 A
5474555 Puno et al. Dec 1995 A
5501684 Schlapfer et al. Mar 1996 A
5520690 Errico et al. May 1996 A
5522899 Michelson Jun 1996 A
5534027 Hodorek Jul 1996 A
5558674 Heggeness et al. Sep 1996 A
5578034 Estes Nov 1996 A
5607426 Ralph et al. Mar 1997 A
5607428 Lin Mar 1997 A
5609635 Michelson Mar 1997 A
5616144 Yapp et al. Apr 1997 A
5643265 Errico et al. Jul 1997 A
5665089 Dall et al. Sep 1997 A
5676666 Oxland et al. Oct 1997 A
5676702 Ratron Oct 1997 A
5681311 Foley et al. Oct 1997 A
5713900 Benzel et al. Feb 1998 A
5735853 Olerud Apr 1998 A
5743914 Skiba Apr 1998 A
5749916 Richelsoph May 1998 A
5755796 Ibo et al. May 1998 A
5766252 Henry et al. Jun 1998 A
5776199 Michelson Jul 1998 A
5807396 Raveh Sep 1998 A
5810823 Klaue et al. Sep 1998 A
5849004 Bramlet Dec 1998 A
5851207 Cesarone Dec 1998 A
5876402 Errico et al. Mar 1999 A
5888223 Bray Mar 1999 A
5888227 Cottle Mar 1999 A
5902303 Eckhof et al. May 1999 A
5904683 Pohndorf et al. May 1999 A
5925048 Ahmad et al. Jul 1999 A
5931838 Vito Aug 1999 A
5951558 Fiz Sep 1999 A
5954722 Bono Sep 1999 A
6001130 Bryan et al. Dec 1999 A
6030389 Wagner et al. Feb 2000 A
6066175 Henderson et al. May 2000 A
6082568 Flanagan Jul 2000 A
6086613 Camino et al. Jul 2000 A
6117173 Taddia et al. Sep 2000 A
6136031 Middleton Oct 2000 A
6139550 Michelson Oct 2000 A
6152927 Farris et al. Nov 2000 A
6156037 Le Huec et al. Dec 2000 A
6193721 Michelson Feb 2001 B1
6206881 Frigg et al. Mar 2001 B1
6206924 Timm Mar 2001 B1
6215093 Meiners et al. Apr 2001 B1
6231610 Geisler May 2001 B1
6235033 Brace et al. May 2001 B1
6235034 Bray May 2001 B1
6235059 Benezech et al. May 2001 B1
6241731 Fiz Jun 2001 B1
6245108 Biscup Jun 2001 B1
6261291 Talaber et al. Jul 2001 B1
6273889 Richelsoph Aug 2001 B1
6287309 Baccelli et al. Sep 2001 B1
6302883 Bono Oct 2001 B1
6306136 Baccelli Oct 2001 B1
6306139 Fuentes Oct 2001 B1
6306170 Rau Oct 2001 B2
6318602 Michelson et al. Nov 2001 B1
6331179 Freid et al. Dec 2001 B1
6342055 Eisermann et al. Jan 2002 B1
6383186 Michelson May 2002 B1
6395035 Bresina et al. May 2002 B2
6402755 Pisharodi Jun 2002 B1
6413259 Lyons et al. Jul 2002 B1
6428542 Michelson Aug 2002 B1
6432106 Fraser Aug 2002 B1
6447544 Michelson Sep 2002 B1
6447547 Michelson Sep 2002 B1
6454769 Wagner et al. Sep 2002 B2
6461359 Tribus et al. Oct 2002 B1
6478823 Michelson Nov 2002 B1
6491724 Ferree Dec 2002 B1
6503250 Paul Jan 2003 B2
6508818 Steiner et al. Jan 2003 B2
6537320 Michelson Mar 2003 B1
6565570 Sterett et al. May 2003 B2
6569168 Lin May 2003 B2
6575975 Brace et al. Jun 2003 B2
6579290 Hardcastle et al. Jun 2003 B1
6582432 Michelson Jun 2003 B1
6599290 Bailey et al. Jul 2003 B2
6602255 Campbell et al. Aug 2003 B1
6602256 Hayes Aug 2003 B1
6605090 Trieu et al. Aug 2003 B1
6613053 Collins et al. Sep 2003 B1
6623486 Weaver et al. Sep 2003 B1
6626907 Campbell et al. Sep 2003 B2
6626911 Engman et al. Sep 2003 B1
6645208 Apfelbaum et al. Nov 2003 B2
6645209 Hall, IV et al. Nov 2003 B2
6652525 Assaker et al. Nov 2003 B1
6656181 Dixon et al. Dec 2003 B2
6656224 Middleton Dec 2003 B2
6660038 Boyer, II et al. Dec 2003 B2
6669700 Farris et al. Dec 2003 B1
6676892 Das et al. Jan 2004 B2
6679883 Hawkes et al. Jan 2004 B2
6682561 Songer et al. Jan 2004 B2
6682563 Scharf Jan 2004 B2
6695845 Dixon et al. Feb 2004 B2
6695846 Richelsoph et al. Feb 2004 B2
6702817 Beger et al. Mar 2004 B2
6719794 Gerber et al. Apr 2004 B2
6730127 Michelson May 2004 B2
6740087 Knox May 2004 B2
6743255 Ferree Jun 2004 B2
6746450 Wall et al. Jun 2004 B1
6755833 Paul et al. Jun 2004 B1
6758849 Michelson Jul 2004 B1
6767369 Boyer, II et al. Jul 2004 B2
6776798 Camino et al. Aug 2004 B2
6780186 Errico et al. Aug 2004 B2
6808537 Michelson Oct 2004 B2
6830570 Frey et al. Dec 2004 B1
6833006 Foley et al. Dec 2004 B2
6835208 Marchosky Dec 2004 B2
6884242 LeHuec et al. Apr 2005 B2
6890334 Brace et al. May 2005 B2
6890335 Grabowski et al. May 2005 B2
6890355 Michelson May 2005 B2
6932610 Ono et al. Aug 2005 B2
6962606 Michelson Nov 2005 B2
6964664 Freid et al. Nov 2005 B2
6974480 Messerli et al. Dec 2005 B2
6984234 Bray Jan 2006 B2
7001389 Navarro et al. Feb 2006 B1
7001672 Justin et al. Feb 2006 B2
7025769 Ferree Apr 2006 B1
7048739 Konieczynski et al. May 2006 B2
7063701 Michelson Jun 2006 B2
7077844 Michelson Jul 2006 B2
7112222 Fraser et al. Sep 2006 B2
7135024 Cook et al. Nov 2006 B2
7141068 Ross et al. Nov 2006 B2
7172627 Fiere et al. Feb 2007 B2
7182782 Man Feb 2007 B2
7186254 Dinh et al. Mar 2007 B2
7217291 Zucherman et al. May 2007 B2
7220263 Cordaro May 2007 B2
7232463 Falahee Jun 2007 B2
7232464 Mathieu et al. Jun 2007 B2
7235082 Bartish et al. Jun 2007 B2
7273481 Lombardo et al. Sep 2007 B2
7306605 Ross Dec 2007 B2
7309340 Fallin et al. Dec 2007 B2
7473277 Boyer, II et al. Jan 2009 B2
7481829 Baynham et al. Jan 2009 B2
7481830 Wall et al. Jan 2009 B2
7503933 Michelson Mar 2009 B2
7521017 Kunze et al. Apr 2009 B2
7524325 Khalili Apr 2009 B2
7537664 O'Neill et al. May 2009 B2
7540882 Michelson Jun 2009 B2
7547324 Cragg et al. Jun 2009 B2
7621943 Michelson Nov 2009 B2
7628816 Magerl et al. Dec 2009 B2
7641665 Zubok et al. Jan 2010 B2
7641690 Abdou Jan 2010 B2
7651517 Konieczynski et al. Jan 2010 B2
7658766 Melkent et al. Feb 2010 B2
7674294 Karahalios et al. Mar 2010 B2
7674297 Falahee Mar 2010 B2
7693981 Clubb et al. Apr 2010 B2
7708778 Gordon et al. May 2010 B2
7708779 Edie et al. May 2010 B2
7718109 Robb et al. May 2010 B2
7806932 Webb et al. Oct 2010 B2
7819903 Fraser et al. Oct 2010 B2
7837734 Zucherman et al. Nov 2010 B2
7857839 Duong et al. Dec 2010 B2
7892239 Warnick et al. Feb 2011 B2
7914561 Konieczynski et al. Mar 2011 B2
7931840 Michelson Apr 2011 B2
7935137 Gorhan et al. May 2011 B2
7959675 Gately Jun 2011 B2
7963981 Binder et al. Jun 2011 B2
7972366 Richelsoph et al. Jul 2011 B2
7985255 Bray et al. Jul 2011 B2
7998212 Schwab et al. Aug 2011 B2
8025697 McClellan, III et al. Sep 2011 B2
8043293 Warnick Oct 2011 B2
8062375 Glerum et al. Nov 2011 B2
8088163 Kleiner Jan 2012 B1
8100955 Blain et al. Jan 2012 B2
8142886 Noble et al. Mar 2012 B2
8147554 Hansell et al. Apr 2012 B2
8157845 Warnick et al. Apr 2012 B2
8231661 Carls Jul 2012 B2
8252060 Hansell et al. Aug 2012 B2
8267966 McCormack et al. Sep 2012 B2
8268001 Butler et al. Sep 2012 B2
8277510 Kleiner Oct 2012 B2
8282675 Maguire et al. Oct 2012 B2
8282682 Kirschman Oct 2012 B2
8292960 Kleiner Oct 2012 B2
8366777 Matthis et al. Feb 2013 B2
8394125 Assell Mar 2013 B2
8409290 Zamani et al. Apr 2013 B2
8414590 Oh et al. Apr 2013 B2
8425529 Milz et al. Apr 2013 B2
8430930 Hunt Apr 2013 B2
8444650 Warnick et al. May 2013 B2
8470039 Blain Jun 2013 B2
8480745 Liu et al. Jul 2013 B2
8491658 Etminan Jul 2013 B1
8496691 Blain Jul 2013 B2
8496708 Blain Jul 2013 B2
8506636 Dye Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8545566 Niemiec et al. Oct 2013 B2
8556979 Glerum et al. Oct 2013 B2
8579904 Siccardi et al. Nov 2013 B2
8603175 Thibodeau Dec 2013 B2
8617246 Malone Dec 2013 B2
8628578 Miller et al. Jan 2014 B2
8632595 Weiman Jan 2014 B2
8652137 Blain et al. Feb 2014 B2
8652143 McClellan, III et al. Feb 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685095 Miller et al. Apr 2014 B2
8685098 Glerum et al. Apr 2014 B2
8690949 Messerli et al. Apr 2014 B2
8696721 Blain Apr 2014 B2
8702798 Matthis et al. Apr 2014 B2
8709086 Glerum Apr 2014 B2
8715355 Kleiner May 2014 B2
8728387 Jones et al. May 2014 B2
8740942 Blain Jun 2014 B2
8758443 Ullrich, Jr. et al. Jun 2014 B2
8795366 Varela Aug 2014 B2
8795370 Man Aug 2014 B2
8801785 Brittan et al. Aug 2014 B2
8801791 Soo et al. Aug 2014 B2
8801793 McKay Aug 2014 B2
8801794 Blain Aug 2014 B2
8843229 Vanasse et al. Sep 2014 B2
8845731 Weiman Sep 2014 B2
8888853 Glerum et al. Nov 2014 B2
8888854 Glerum et al. Nov 2014 B2
8926704 Glerum et al. Jan 2015 B2
8986307 Kirschman Mar 2015 B2
8986383 Castro Mar 2015 B2
8992703 O'Neill et al. Mar 2015 B2
8998924 Simpson et al. Apr 2015 B2
9060873 Abdou Jun 2015 B2
9078706 Man Jul 2015 B2
9095385 Wallenstein et al. Aug 2015 B2
9101410 Urrea Aug 2015 B1
9138327 McClellan, III Sep 2015 B1
9138330 Hansell et al. Sep 2015 B2
9198772 Weiman Dec 2015 B2
9204974 Glerum et al. Dec 2015 B2
9220542 Kerboul et al. Dec 2015 B2
9220547 Blain et al. Dec 2015 B2
9226836 Glerum Jan 2016 B2
9259327 Niemiec et al. Feb 2016 B2
9265546 Blain Feb 2016 B2
9271765 Blain Mar 2016 B2
9271845 Hunt et al. Mar 2016 B2
9320610 Alheidt et al. Apr 2016 B2
9358126 Glerum et al. Jun 2016 B2
9399086 Melkent et al. Jul 2016 B2
9402736 Etminan Aug 2016 B2
9415137 Meridew et al. Aug 2016 B2
9421108 Hunt Aug 2016 B2
9427328 Drochner et al. Aug 2016 B2
9433707 Swords et al. Sep 2016 B2
9439778 Biedermann et al. Sep 2016 B2
9456901 Jones et al. Oct 2016 B2
9463099 Levy et al. Oct 2016 B2
9545317 Hunt Jan 2017 B2
9549823 Hunt et al. Jan 2017 B2
9554918 Weiman Jan 2017 B2
9572669 Hunt et al. Feb 2017 B2
9585707 Blain Mar 2017 B2
9615934 Khurana Apr 2017 B2
9636226 Hunt May 2017 B2
9662223 Matthis et al. May 2017 B2
9662226 Wickham May 2017 B2
9668876 Blain et al. Jun 2017 B2
9700428 Niemiec et al. Jul 2017 B2
9707317 Hunter et al. Jul 2017 B2
9757235 Hunt et al. Sep 2017 B2
9757247 Mantri Sep 2017 B2
9770343 Weiman Sep 2017 B2
9782269 Hansell et al. Oct 2017 B2
RE46647 Messerli et al. Dec 2017 E
9867713 Milz et al. Jan 2018 B2
9889020 Baynham Feb 2018 B2
9936984 Blain Apr 2018 B2
9949841 Glerum et al. Apr 2018 B2
9962271 Glerum May 2018 B2
9968462 Weiman May 2018 B2
9980823 Matthis et al. May 2018 B2
9980825 Nichols et al. May 2018 B2
9987051 Nunley et al. Jun 2018 B2
9987149 Simpson et al. Jun 2018 B2
10004607 Weiman et al. Jun 2018 B2
10022245 Frasier et al. Jul 2018 B2
10028841 Moore et al. Jul 2018 B2
10034770 Etminan Jul 2018 B2
10064737 Tsai et al. Sep 2018 B2
10092412 Drochner et al. Oct 2018 B2
10130490 Hansell et al. Nov 2018 B2
10154912 Glerum Dec 2018 B2
10245152 Kloss Apr 2019 B2
10271957 Niemiec et al. Apr 2019 B2
10299938 Ehteshami May 2019 B1
10369009 Joly et al. Aug 2019 B2
10470892 Abdou Nov 2019 B2
10478313 Sweeney, III Nov 2019 B1
10512545 Arnone Dec 2019 B2
10555819 Miccio Feb 2020 B2
10568664 Blain et al. Feb 2020 B2
10610373 Jang et al. Apr 2020 B2
10660763 Wilson et al. May 2020 B2
10667927 Lamborne et al. Jun 2020 B2
10687876 Vrionis et al. Jun 2020 B2
10702397 Simpson et al. Jul 2020 B2
10758361 Blain Sep 2020 B2
10765525 Sansur et al. Sep 2020 B2
10905567 Kuyler et al. Feb 2021 B2
10993810 Magagnoli May 2021 B2
11026801 Suh et al. Jun 2021 B2
11147682 Trudeau et al. Oct 2021 B2
11213404 Foley et al. Jan 2022 B2
20010007941 Steiner et al. Jul 2001 A1
20010014807 Wagner et al. Aug 2001 A1
20010047207 Michelson Nov 2001 A1
20020004683 Michelson Jan 2002 A1
20020016595 Michelson Feb 2002 A1
20020022843 Michelson Feb 2002 A1
20020045898 Freid et al. Apr 2002 A1
20020116064 Middleton Aug 2002 A1
20020147450 LeHuec et al. Oct 2002 A1
20020151895 Soboleski et al. Oct 2002 A1
20020169507 Malone Nov 2002 A1
20020169508 Songer et al. Nov 2002 A1
20030093082 Campbell et al. May 2003 A1
20030135279 Michelson Jul 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20030167091 Scharf Sep 2003 A1
20030171753 Collins et al. Sep 2003 A1
20030187442 Richelsoph et al. Oct 2003 A1
20030199876 Brace et al. Oct 2003 A1
20030212399 Dinh et al. Nov 2003 A1
20040010254 Cook et al. Jan 2004 A1
20040068319 Cordaro Apr 2004 A1
20040087951 Khalili May 2004 A1
20040097935 Richelsoph et al. May 2004 A1
20040127900 Konieczynski et al. Jul 2004 A1
20040127904 Konieczynski et al. Jul 2004 A1
20040176778 Zubok et al. Sep 2004 A1
20040181227 Khalili Sep 2004 A1
20040210217 Baynham et al. Oct 2004 A1
20040210219 Bray Oct 2004 A1
20040220570 Frigg et al. Nov 2004 A1
20040230192 Graf Nov 2004 A1
20040260306 Fallin et al. Dec 2004 A1
20050027296 Thramann et al. Feb 2005 A1
20050033433 Michelson Feb 2005 A1
20050049593 Duong et al. Mar 2005 A1
20050085913 Fraser et al. Apr 2005 A1
20050101960 Fiere et al. May 2005 A1
20050277933 Wall et al. May 2005 A1
20050149191 Cragg et al. Jul 2005 A1
20050159746 Grab et al. Jul 2005 A1
20050177237 Shappley et al. Aug 2005 A1
20050177245 Leatherbury et al. Aug 2005 A1
20050192576 Michelson Sep 2005 A1
20060074488 Abdou Apr 2006 A1
20060122604 Gorhan et al. Jun 2006 A1
20060200147 Ensign et al. Sep 2006 A1
20060224241 Butler et al. Oct 2006 A1
20060235403 Blain Oct 2006 A1
20060235409 Blain Oct 2006 A1
20060235418 Gil et al. Oct 2006 A1
20060235533 Blain Oct 2006 A1
20060241597 Mitchell Oct 2006 A1
20060241616 Konieczynski et al. Oct 2006 A1
20060247650 Yerby Nov 2006 A1
20070055252 Blain et al. Mar 2007 A1
20070055373 Hudgins et al. Mar 2007 A1
20070123863 Winslow et al. May 2007 A1
20070135814 Farris Jun 2007 A1
20070213820 Magerl et al. Sep 2007 A1
20070250166 McKay Oct 2007 A1
20070255414 Melkent et al. Nov 2007 A1
20070282446 Li Dec 2007 A1
20080103598 Trudeau et al. May 2008 A1
20080161925 Brittan Jul 2008 A1
20080167686 Trieu et al. Jul 2008 A1
20080177390 Mitchell Jul 2008 A1
20090072006 Clauson et al. Mar 2009 A1
20090182430 Tyber Jul 2009 A1
20090198339 Kleiner et al. Aug 2009 A1
20090270929 Suddaby Oct 2009 A1
20100070037 Parry Mar 2010 A1
20100249937 Blain et al. Sep 2010 A1
20110015744 Squires et al. Jan 2011 A1
20110015745 Bucci Jan 2011 A1
20110040384 Junn et al. Feb 2011 A1
20110153020 Abdelgany et al. Jun 2011 A1
20110172775 Flickinger et al. Jul 2011 A1
20110224796 Weiland et al. Sep 2011 A1
20120016480 Gerber et al. Jan 2012 A1
20120046749 Tatsumi Feb 2012 A1
20120197402 Blackwell et al. Aug 2012 A1
20120277801 Marik et al. Nov 2012 A1
20130030529 Hunt Jan 2013 A1
20130110238 Lindemann et al. May 2013 A1
20130110248 Zipnick May 2013 A1
20130123923 Pavlov et al. May 2013 A1
20130181015 Cason Jul 2013 A1
20130197643 Greenberg et al. Aug 2013 A1
20130197646 Blain Aug 2013 A1
20130253590 Blain Sep 2013 A1
20130268078 Richelsoph Oct 2013 A1
20130297024 Khurana Nov 2013 A1
20130325129 Huang Dec 2013 A1
20140012318 Goel Jan 2014 A1
20140066758 Marik et al. Mar 2014 A1
20140094922 Abdou Apr 2014 A1
20140309741 Ganter et al. Oct 2014 A1
20140324173 Kirschman Oct 2014 A1
20140336768 Blain Nov 2014 A1
20150173917 Radcliffe et al. Jun 2015 A1
20150342648 McCormack et al. Dec 2015 A1
20160000576 Kirschman Jan 2016 A1
20160022438 Lamborne et al. Jan 2016 A1
20160213481 Blain Jul 2016 A1
20160213485 Schaufler et al. Jul 2016 A1
20160296338 Kim et al. Oct 2016 A1
20170189077 Blain Jul 2017 A1
20170231782 Perez-Cruet et al. Aug 2017 A1
20170333205 Joly et al. Nov 2017 A1
20180014947 Baynham Jan 2018 A1
20180104063 Asaad Apr 2018 A1
20180214279 Etminan et al. Aug 2018 A1
20180235769 Levy et al. Aug 2018 A1
20180250051 Vrionis et al. Sep 2018 A1
20180289508 Glerum Oct 2018 A1
20180325693 Weiman et al. Nov 2018 A1
20190046333 Hansell et al. Feb 2019 A1
20190091036 Levy et al. Mar 2019 A1
20190133785 Georges May 2019 A1
20190175357 Sharabani Jun 2019 A1
20190254840 Gray et al. Aug 2019 A1
20200000608 Bullard et al. Jan 2020 A1
20200093612 Blain et al. Mar 2020 A1
20200229943 Abdou Jul 2020 A1
20200315679 Vrionis et al. Oct 2020 A1
20200345503 Sansur et al. Nov 2020 A1
20200345505 Etminan et al. Nov 2020 A1
20210137702 Neubardt May 2021 A1
20210145600 Sharifi-Mehr et al. May 2021 A1
20210145607 Kuyler et al. May 2021 A1
20210154021 Bae et al. May 2021 A1
Foreign Referenced Citations (39)
Number Date Country
1 329 525 May 1994 CA
30 27 138 Dec 1981 DE
30 27 148 Dec 1981 DE
297 01 099 Apr 1997 DE
197 02 201 Aug 1998 DE
20 2004 015 912 Dec 2004 DE
0 242 842 Oct 1987 EP
0 974 319 Jan 2000 EP
1 029 510 Aug 2000 EP
1 346 697 Sep 2003 EP
1 470 803 Oct 2004 EP
2 766 353 Jan 1999 FR
2 813 519 Mar 2002 FR
2 859 904 Mar 2005 FR
2002-515287 May 2002 JP
2003-518977 Jun 2003 JP
2004-500156 Jan 2004 JP
2008-522787 Jul 2008 JP
2008-537498 Sep 2008 JP
2010-510852 Apr 2010 JP
2014-523751 Sep 2014 JP
2015-500701 Jan 2015 JP
WO 88003781 Jun 1988 WO
WO 89004150 May 1989 WO
WO 93010725 Jun 1993 WO
WO 94000066 Jan 1994 WO
WO 95035067 Dec 1995 WO
WO 00024343 May 2000 WO
WO 01003570 Jan 2001 WO
WO 01049191 Jul 2001 WO
WO 01078615 Oct 2001 WO
WO 01089428 Nov 2001 WO
WO 03017856 Mar 2003 WO
WO 03071966 Sep 2003 WO
WO 2004006792 Jan 2004 WO
WO 2005027760 Mar 2005 WO
WO 2006020464 Feb 2006 WO
WO 2020219789 Oct 2020 WO
WO 2021055363 Mar 2021 WO
Non-Patent Literature Citations (50)
Entry
Official Communication in Australian Application No. 2006227755, dated Dec. 8, 2010.
Official Communication in Australian Application No. 2012211502, dated Jul. 17, 2013.
Notice of Acceptance in Australian Application No. 2012211502, dated Sep. 10, 2014.
Official Communication in Australian Application No. 2014274519, dated Sep. 17, 2015.
Official Communication in Australian Application No. 2014274519, dated Jun. 17, 2016.
Official Communication in Australian Application No. 2014274519, dated Aug. 26, 2016.
Notice of Acceptance in Australian Application No. 2014274519, dated Sep. 22, 2016.
Official Communication in Australian Application No. 2016277588, dated Sep. 7, 2017.
Official Communication in European Application No. 06738204.4, dated Mar. 26, 2009.
Official Communication in European Application No. 06738204.4, dated Apr. 6, 2010.
Official Communication in European Application No. 06738204.4, dated Apr. 5, 2011.
Official Communication in European Application No. 06738204.4, dated Oct. 28, 2011.
Official Communication in European Application No. 06738204.4, dated Jul. 18, 2012.
Official Communication in European Application No. 06738204.4, dated Oct. 14, 2013.
Extended European Search Report for European Application No. 11160061.5, dated Nov. 2, 2011.
Official Communication in European Application No. 11160061.5, dated Jul. 9, 2012.
Extended European Search Report for European Application No. 11160063.1, dated Nov. 2, 2011.
Official Communication in European Application No. 11160063.1, dated Jul. 12, 2012.
Official Communication in European Application No. 11160063.1, dated Nov. 27, 2012.
Official Communication in European Application No. 11160063.1, dated Oct. 14, 2013.
Official Communication in European Application No. 14190344.3, dated Feb. 10, 2015.
Official Communication in European Application No. 14190344.3, dated Jan. 4, 2016.
Official Communication in European Application No. 14190344.3, dated Sep. 8, 2016.
Official Communication in European Application No. 18150661.9, dated May 25, 2018.
Official Communication in Japanese Application No. 2008-501962, dated May 10, 2011.
Official Communication in Japanese Application No. 2008-501962, dated Nov. 13, 2012.
Official Communication in Japanese Application No. 2011-210533, dated Mar. 5, 2013.
Official Communication in Japanese Application No. 2011-210533, dated Dec. 3, 2013.
Notice of Allowance in Japanese Application No. 2011-210533, dated May 7, 2014.
Notice of Allowance in Japanese Application No. 2013-117602, dated May 7, 2014.
International Search Report and Written Opinion in International Application No. PCT/US2006/009120, dated Oct. 20, 2006.
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2006/009120, dated Sep. 18, 2007.
Official Communication in European Application No. 16743832.4, dated Jul. 24, 2018.
International Search Report and Written Opinion in International Application No. PCT/US2016/013062, dated Mar. 16, 2016.
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2016/013062, dated Aug. 10, 2017.
Official Communication in Australian Application No. 2018271345, dated Jul. 31, 2019.
Official Communication in European Application No. 18150661.9, dated Aug. 23, 2019.
Official Communication in Australian Application No. 2016212009, dated Sep. 6, 2019.
Official Communication in Japanese Application No. 2017-557269, dated Oct. 21, 2019.
Official Communication in Australian Application No. 2016212009, dated May 26, 2020.
Official Communication in Australian Application No. 2016212009, dated Jul. 14, 2020.
Official Communication in Austra2020281016lian Application No. 2016212009, dated Nov. 24, 2021.
Official Communication in Canadian Application No. 2,972,788, dated Jan. 31, 2022.
Official Communication in Japanese Application No. 2017-557269, dated Jul. 13, 2020.
Official Communication in Japanese Application No. 2017-557269, dated Nov. 1, 2021.
Official Communication in Japanese Application No. 2020-181320, Sep. 21, 2021.
Invitation to Pay Additional Search Fees in International Application No. PCT/US2019/052211, dated Nov. 14, 2019.
International Search Report and Written Opinion in International Application No. PCT/US2019/052211, dated Feb. 3, 2020.
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/052211, dated Apr. 1, 2021.
Invitation to Pay Additional Search Fees in International Application No. PCT/US2021/072334, dated Jan. 13, 2022.
Related Publications (1)
Number Date Country
20200146729 A1 May 2020 US
Provisional Applications (1)
Number Date Country
61164029 Mar 2009 US
Divisions (1)
Number Date Country
Parent 12748333 Mar 2010 US
Child 14938503 US
Continuations (1)
Number Date Country
Parent 14938503 Nov 2015 US
Child 16743677 US